Kore Private Wealth LLC - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 58 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
Kore Private Wealth LLC ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$105,000
-31.4%
202,3660.0%0.02%
-35.5%
Q2 2020$153,000
-25.7%
202,3660.0%0.03%
-36.7%
Q1 2020$206,000
+27.2%
202,366
+93.9%
0.05%
+58.1%
Q4 2019$162,000
-9.5%
104,3660.0%0.03%
-22.5%
Q3 2019$179,000
+4.7%
104,3660.0%0.04%
+2.6%
Q2 2019$171,000
-8.6%
104,3660.0%0.04%
-7.1%
Q1 2019$187,000
+30.8%
104,366
+37.6%
0.04%
+7.7%
Q4 2018$143,00075,8660.04%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 41,909,219$21,793,00011.58%
Kore Private Wealth LLC 202,366$105,0000.02%
BARD ASSOCIATES INC 335,750$175,0000.02%
HighTower Advisors, LLC 5,284,688$2,738,0000.01%
GSA CAPITAL PARTNERS LLP 126,529$66,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 654,200$339,0000.01%
Virtu Financial LLC 57,076$30,0000.01%
WEDBUSH SECURITIES INC 81,500$42,0000.00%
NEXPOINT ASSET MANAGEMENT, L.P. 33,933$18,0000.00%
MATRIX ASSET ADVISORS INC/NY 39,500$20,0000.00%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders